Zhang L, Chen J, Liu Y, Zhang Y, Hong L, Li X
Front Oncol. 2024; 14:1341056.
PMID: 39525623
PMC: 11544118.
DOI: 10.3389/fonc.2024.1341056.
Yi Q, Zhu G, Zhu W, Wang J, Ouyang X, Yang K
Heliyon. 2024; 10(18):e37527.
PMID: 39309878
PMC: 11415682.
DOI: 10.1016/j.heliyon.2024.e37527.
Yang X, Xu C, Liu C, Wu X, Chen X, Hou J
Funct Integr Genomics. 2024; 24(4):123.
PMID: 38992207
DOI: 10.1007/s10142-024-01403-1.
Liu Y, Liu Y, Ye S, Feng H, Ma L
J Transl Int Med. 2023; 11(2):145-155.
PMID: 38025952
PMC: 10680379.
DOI: 10.2478/jtim-2023-0089.
Xu H, Lu M, Liu Y, Ren F, Zhu L
J Cancer. 2023; 14(16):3151-3168.
PMID: 37859811
PMC: 10583579.
DOI: 10.7150/jca.88485.
LncRNA LINC01094 Promotes Cells Proliferation and Metastasis through the PTEN/AKT Pathway by Targeting AZGP1 in Gastric Cancer.
Gong Z, Zhang Y, Yang Y, Yang Y, Zhang J, Wang Y
Cancers (Basel). 2023; 15(4).
PMID: 36831602
PMC: 9954187.
DOI: 10.3390/cancers15041261.
An immune infiltration-related long non-coding RNAs signature predicts prognosis for hepatocellular carcinoma.
Li G, Xu S, Yang S, Wu C, Zhang L, Wang H
Front Genet. 2022; 13:1029576.
PMID: 36568382
PMC: 9773198.
DOI: 10.3389/fgene.2022.1029576.
Identification of potential regulatory long non-coding RNA-associated competing endogenous RNA axes in periplaque regions in multiple sclerosis.
Sabaie H, Rouz S, Kouchakali G, Heydarzadeh S, Asadi M, Sharifi-Bonab M
Front Genet. 2022; 13:1011350.
PMID: 36324503
PMC: 9619104.
DOI: 10.3389/fgene.2022.1011350.
Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
Zhou L, Fang H, Guo F, Yin M, Long H, Weng G
J Clin Lab Anal. 2022; 36(8):e24582.
PMID: 35808868
PMC: 9396193.
DOI: 10.1002/jcla.24582.
Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma.
Gu J, He Z, Huang Y, Luan T, Chen Z, Wang J
Dis Markers. 2022; 2022:5204831.
PMID: 35664432
PMC: 9157284.
DOI: 10.1155/2022/5204831.
Construction of a Prognostic Signature of 10 Autophagy-Related lncRNAs in Gastric Cancer.
Wang W, Pei Q, Wang L, Mu T, Feng H
Int J Gen Med. 2022; 15:3699-3710.
PMID: 35411177
PMC: 8994655.
DOI: 10.2147/IJGM.S348943.
Upregulated long intergenic non-protein coding RNA 1094 (LINC01094) is linked to poor prognosis and alteration of cell function in colorectal cancer.
Zhang G, Gao Y, Yu Z, Su H
Bioengineered. 2022; 13(4):8526-8537.
PMID: 35287563
PMC: 9161846.
DOI: 10.1080/21655979.2022.2051839.
LINC01094 Predicts Poor Prognosis in Patients With Gastric Cancer and is Correlated With EMT and Macrophage Infiltration.
Ye Y, Ge O, Zang C, Yu L, Eucker J, Chen Y
Technol Cancer Res Treat. 2022; 21:15330338221080977.
PMID: 35254147
PMC: 8905065.
DOI: 10.1177/15330338221080977.
Ferroptosis‑related long non‑coding RNAs and the roles of LASTR in stomach adenocarcinoma.
Wang G, Sun L, Wang S, Guo J, Xiao R, Li W
Mol Med Rep. 2022; 25(4).
PMID: 35137922
PMC: 8855154.
DOI: 10.3892/mmr.2022.12634.
Aerial View of the Association Between m6A-Related LncRNAs and Clinicopathological Characteristics of Pancreatic Cancer.
Huang B, Liu J, Lu J, Gao W, Zhou L, Tian F
Front Oncol. 2022; 11:812785.
PMID: 35047414
PMC: 8762256.
DOI: 10.3389/fonc.2021.812785.
Targeting AVIL, a New Cytoskeleton Regulator in Glioblastoma.
Cornelison R, Marrah L, Horter D, Lynch S, Li H
Int J Mol Sci. 2021; 22(24).
PMID: 34948433
PMC: 8706274.
DOI: 10.3390/ijms222413635.
LINC02532 Contributes to Radiosensitivity in Clear Cell Renal Cell Carcinoma through the miR-654-5p/YY1 Axis.
Zhou X, Zeng B, Li Y, Wang H, Zhang X
Molecules. 2021; 26(22).
PMID: 34834139
PMC: 8625588.
DOI: 10.3390/molecules26227040.
serves as a novel biomarker and promotes tumour progression by sponging miR-204-5p and upregulating RAB22A in clear cell renal cell carcinoma.
Liu Q, Lei C
Ann Med. 2021; 53(1):2153-2164.
PMID: 34783622
PMC: 8604453.
DOI: 10.1080/07853890.2021.2001563.
LncRNA LINC01094 contributes to glioma progression by modulating miR-224-5p/CHSY1 axis.
Liu L, Xu Q, Xiong Y, Deng H, Zhou J
Hum Cell. 2021; 35(1):214-225.
PMID: 34716872
DOI: 10.1007/s13577-021-00637-6.
Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis.
Wu X, Kong C, Wu Y
Bioengineered. 2021; 12(1):9046-9057.
PMID: 34657558
PMC: 8806954.
DOI: 10.1080/21655979.2021.1993715.